Research and Development
AbbVie’s Imbruvica secures fourth breakthrough therapy designation from US FDA
July 1, 2016 Medical Communications, Research and Development, Sales and Marketing AbbVie, US FDA, drug trial, imbruvica
Shire says Phase II trial for rare eye condition in premature infants fails
July 1, 2016 Medical Communications, Research and Development Shire, US FDA, drug trial, rare eye condition in infants
Bayer says its Stivarga improved overall survival in liver cancer in late-stage trials
June 30, 2016 Research and Development, Sales and Marketing Bayer, Stivarga, drug trial, liver cancer
Galena’s breast cancer immunotherapy fails in late-stage trials; shares plunge
June 30, 2016 Research and Development, Sales and Marketing Galena Biopharma, Stock, breast cancer, drug trial
Tesaro’s niraparib hits primary goal in late-stage trials for ovarian cancer trial; shares jump
June 30, 2016 Research and Development, Sales and Marketing Tesaro, drug trial, niraparib, ovarian cancer
Eli Lilly says FDA panel backs approval of Jardiance for cardiovascular indication
June 30, 2016 Research and Development, Sales and Marketing Eli Lilly, cardiovascular, diabetes, jardiance
Shire says trial drug for ADHD shows positive results
June 30, 2016 Research and Development, Sales and Marketing ADHD, Shire, US FDA, drug trial, regulation
Regulus’ shares drop as FDA puts trials for hepatitis C drug on hold
June 29, 2016 Research and Development, Sales and Marketing Regulus Therapeutics, US FDA, drug trial, hepatitis C virus, regulation
Mayne Pharma to buy a portfolio of Teva’s generic drugs for $652 million
June 29, 2016 Research and Development, Sales and Marketing Allergan, Deals, Mayne Pharma, Teva, generics, merger and acquisition
Pfizer to invest about $350 million in China biotech facility, first in Asia
June 29, 2016 Research and Development, Sales and Marketing Biotech Plant, China, Pfizer, research
Gilead says US FDA approves Epclusa to treat hepatitis C
June 29, 2016 Research and Development, Sales and Marketing Epclusa, Gilead, HCV, US FDA, drug approval, regulation
AstraZeneca’s new antibiotic Zavicefta gets European approval for serious bacterial infections
June 29, 2016 Research and Development, Sales and Marketing AstraZeneca, European Commission, Zavicefta, bacterial infections, regulation
Roche says EMA accepts its marketing applications for Ocrevus to treat multiple sclerosis
June 28, 2016 Manufacturing and Production, Research and Development, Sales and Marketing EMA, Ocrevus, Roche, US FDA, drug development, drug trial, multiple sclerosis, priority review, regulation
Novo Nordisk says its insulin pump secures EMA marketing authorisation
June 28, 2016 Manufacturing and Production, Research and Development, Sales and Marketing EMA, Novo Nordisk, insulin pump, marketing, product launch
Bristol-Myers Squibb’s Opdivo gets US FDA breakthrough therapy designation for advanced bladder cancer
June 28, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Breakthrough Therapy Designation, Bristol-Myers Squibb, FDA, bladder cancer, opdivo, regulation
